Initial experience with a new fibrinolytic agent (APSAC) in patients with major pulmonary embolism.
Bett
J H
JH
Bunce
I H
IH
Cade
J F
JF
Concannon
A J
AJ
Gallus
A
A
Low
J
J
D000368:Aged; D016255:Anistreplase; D002986:Clinical Trials as Topic; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use*
D016255:Anistreplase; D010958:Plasminogen; D013300:Streptokinase